Saks appoints Clairol exec
This article was originally published in The Rose Sheet
Executive Summary
Bristol-Myers Squibb Senior VP Stephen Sadove joins retailer's management team as vice chairman, Saks Fifth Avenue announces. Exec will be responsible for operating plans, performance management and identification of brand extensions and new business opportunities, company says. Sadove worked most recently at BMS as president of worldwide beauty care and nutritionals. Exec joined BMS in 1991 as Clairol president and became president of worldwide beauty care in 1996. Under Sadove, BMS sold its Clairol hair care business to Procter & Gamble (1"The Rose Sheet" May 28, 2001, p. 3)...
You may also be interested in...
Clairol $50 Mil. Marketing Boost Part Of P&G Blueprint For Growth
Procter & Gamble plans to increase marketing spending on Clairol by approximately $50 mil. within its first year of acquiring the hair care business to "restore competitive marketing," President and CEO A.G. Lafley said during a May 21 analyst meeting outlining plans for the purchase.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.